Loading stock data…
$9.23-0.03 (-0.27%)
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally.
Orthofix Medical Inc. in the Healthcare sector is trading at $9.23 with a market capitalization of $351M. Wall Street consensus targets $13.00 (4 analysts), implying a +40.8% move over the next 12 months. The stock is currently near its 52-week low of $8.50, remaining 19.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $210.93M↑ | $196.71M↓ | $219.91M↑ | $205.63M↑ | $203.12M |
| Gross Profit | $149.71M↑ | $139.55M↓ | $156.34M↑ | $148.52M↑ | $139.53M |
| Operating Income | -$7.27M↑ | -$13.69M↓ | $1.15M↑ | -$17.47M↓ | -$16.77M |
| Net Income | -$15.80M↑ | -$20.91M↓ | -$2.22M↑ | -$22.80M↓ | -$14.08M |
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global L...